INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique

NCT03780192 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-03-17

No results posted yet for this study

Summary

Evaluate the efficacy of the Inspiron Sirolimus Eluting Stent on bifurcation coronary artery lesions, in order to preserve and not compromize the side branch using the provisional stent technique.

Conditions

Interventions

DEVICE

Inspiron Sirolimus Eluting Stent

Bifurcation treatment using provisional stent technique

Sponsors & Collaborators

  • Scitech Produtos Medicos Ltda

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2021-02-15
Completion
2022-02-15

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03780192 on ClinicalTrials.gov